Leslie J. Williams, Director at OCULAR THERAPEUTIX, INC (OCUL), bought 4,500 shares at $4.40 ($20K) on 2019-06-14, disclosed to the SEC on 2019-06-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.